Cargando…

Novel Cytotoxic Chemotherapies in Small Cell Lung Carcinoma

SIMPLE SUMMARY: Small cell lung cancer is a subtype of lung cancer and one of the deadliest thoracic tumours. Historically, chemotherapy consisting of either platinum plus etoposide or anthracycline-based regimens have been associated with a high response rate and rapid development of acquired resis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cortinovis, Diego, Bidoli, Paolo, Canova, Stefania, Colonese, Francesca, Gemelli, Maria, Lavitrano, Maria Luisa, Banna, Giuseppe Luigi, Liu, Stephen V., Morabito, Alessandro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7962524/ https://www.ncbi.nlm.nih.gov/pubmed/33800236 http://dx.doi.org/10.3390/cancers13051152

Ejemplares similares

Focus on Nivolumab in NSCLC
por: Cortinovis, Diego L., et al.
Publicado: (2016)

Duration of Immunotherapy in Non-Small Cell Lung Cancer Survivors: A Lifelong Commitment?
por: Putzu, Carlo, et al.
Publicado: (2023)

Novel Therapeutic Options for Small Cell Lung Cancer
por: Canova, Stefania, et al.
Publicado: (2023)

Targeted therapies and immunotherapy in non-small-cell lung cancer
por: Cortinovis, D, et al.
Publicado: (2016)

Harnessing DLL3 inhibition: From old promises to new therapeutic horizons
por: Cortinovis, Diego Luigi, et al.
Publicado: (2022)

Editorial: Small cell lung cancer: New drugs and strategies
por: Cortinovis, Diego L., et al.
Publicado: (2023)

Diagnostic and prognostic biomarkers in oligometastatic non-small cell lung cancer: a literature review
por: Cortinovis, Diego, et al.
Publicado: (2021)

Budget Impact di afatinib per il trattamento in prima linea del Non Small Cell Lung Cancer (NSCLC) con mutazioni non comuni EGFR
por: Pompilio, Giuseppe, et al.
Publicado: (2022)

Sneaky Diagnosis of Pleural Malignant Mesothelioma in Thoracic Surgery: All That Glitters Is Not Gold
por: Orlandi, Riccardo, et al.
Publicado: (2022)

Differential influence of antibiotic therapy and other medications on oncological outcomes of patients with non-small cell lung cancer treated with first-line pembrolizumab versus cytotoxic chemotherapy
por: Cortellini, Alessio, et al.
Publicado: (2021)

Metabolic Parameters as Biomarkers of Response to Immunotherapy and Prognosis in Non-Small Cell Lung Cancer (NSCLC): A Real World Experience
por: Monaco, Lavinia, et al.
Publicado: (2021)

Immune Checkpoint Inhibitors in Malignant Pleural Mesothelioma: A Systematic Review and Meta-Analysis
por: Gemelli, Maria, et al.
Publicado: (2022)

Efficacy and tolerability of paclitaxel, ifosfamide, and cisplatin as a neoadjuvant chemotherapy in locally advanced cervical carcinoma
por: Scandurra, Giuseppa, et al.
Publicado: (2015)

Chemotherapy in Combination With Immune Checkpoint Inhibitors for the First-Line Treatment of Patients With Advanced Non-small Cell Lung Cancer: A Systematic Review and Literature-Based Meta-Analysis
por: Addeo, Alfredo, et al.
Publicado: (2019)

An Overview of PARP Resistance in Ovarian Cancer from a Molecular and Clinical Perspective
por: Cordani, Nicoletta, et al.
Publicado: (2023)

C-Arm Cone-Beam CT-Guided Transthoracic Lung Core Needle Biopsy as a Standard Diagnostic Tool: An Observational Study
por: Jaconi, Marta, et al.
Publicado: (2015)

Tarlatamab: a potential new option for recurrent small cell lung cancer
por: Addeo, Alfredo, et al.
Publicado: (2023)

Molecular and Immune Biomarkers for Cutaneous Melanoma: Current Status and Future Prospects
por: Pilla, Lorenzo, et al.
Publicado: (2020)

Identifying successful biomarkers for patients with non-small-cell lung cancer
por: Friedlaender, Alex, et al.
Publicado: (2019)

Editorial: Beyond chemotherapy and immunotherapy in thoracic malignancies: Overcoming resistance by tackling new molecular pathways
por: Mountzios, Giannis, et al.
Publicado: (2022)

Induction of natural killer antibody-dependent cell cytotoxicity and of clinical activity of cetuximab plus avelumab in non-small cell lung cancer
por: Fasano, Morena, et al.
Publicado: (2020)

Liquid Biopsy Testing Can Improve Selection of Advanced Non-Small-Cell Lung Cancer Patients to Rechallenge with Gefitinib
por: Esposito Abate, Riziero, et al.
Publicado: (2019)

From expert recommendations to multidisciplinary team decisions: a way to set out the novel perioperative options for patients with non-small-cell lung cancer
por: Banna, Giuseppe Luigi, et al.
Publicado: (2022)

The Pleiotropic Effects of Vitamin D in Gynaecological and Obstetric Diseases: An Overview on a Hot Topic
por: Colonese, Francesca, et al.
Publicado: (2015)

Host immune‐inflammatory markers to unravel the heterogeneous outcome and assessment of patients with PD‐L1 ≥50% metastatic non‐small cell lung cancer and poor performance status receiving first‐line immunotherapy
por: Banna, Giuseppe L., et al.
Publicado: (2021)

Treatment Patterns, Clinical Outcomes and Healthcare Costs of Advanced Non-Small Cell Lung Cancer: A Real-World Evaluation in Italy
por: Franchi, Matteo, et al.
Publicado: (2021)

Epidemiology, Patients’ Journey and Healthcare Costs in Early-Stage Non-Small-Cell Lung Carcinoma: A Real-World Evidence Analysis in Italy
por: Cortinovis, Diego Luigi, et al.
Publicado: (2023)

Overcoming Resistance to Checkpoint Inhibitors: Natural Killer Cells in Non-Small Cell Lung Cancer
por: Gemelli, Maria, et al.
Publicado: (2022)

Metronomic combination of Vinorelbine and 5Fluorouracil is able to inhibit triple-negative breast cancer cells. Results from the proof-of-concept VICTOR-0 study
por: Cerrito, Maria Grazia, et al.
Publicado: (2018)

Maintenance therapy in NSCLC: why? To whom? Which agent?
por: Novello, Silvia, et al.
Publicado: (2011)

Small Cell Lung Cancer: A New Era Is Beginning?
por: Morabito, Alessandro, et al.
Publicado: (2021)

Surgery in Small-Cell Lung Cancer
por: Martucci, Nicola, et al.
Publicado: (2021)

Lurbinectedin in small cell lung cancer
por: Manzo, Anna, et al.
Publicado: (2022)

Searching for Small Molecules as Antibacterials: Non-Cytotoxic Diarylureas Analogues of Triclocarban
por: Catalano, Alessia, et al.
Publicado: (2021)

Plasma biomarkers of clinical response during chemotherapy plus combination antiretroviral therapy (cART) in HIV+ patients with advanced Kaposi sarcoma
por: Tedeschi, Rosamaria, et al.
Publicado: (2015)

Evaluation of azacitidine and entinostat as sensitization agents to cytotoxic chemotherapy in preclinical models of non-small cell lung cancer
por: Vendetti, Frank P., et al.
Publicado: (2014)

The Association between Vitamin D and Gut Microbiota: A Systematic Review of Human Studies
por: Bellerba, Federica, et al.
Publicado: (2021)

Vitamin D Supplementation and Cancer Mortality: Narrative Review of Observational Studies and Clinical Trials
por: Gnagnarella, Patrizia, et al.
Publicado: (2021)

Residential Proximity to Major Roadways and Lung Cancer Mortality. Italy, 1990–2010: An Observational Study
por: Bidoli, Ettore, et al.
Publicado: (2016)

Chemotherapy-induced neutropenia and treatment efficacy in advanced non-small-cell lung cancer: a pooled analysis of 6 randomized trials
por: Gargiulo, Piera, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_pmsfgp0lu217gee85nnjgmb9a2